Chickenpox, chickenpox vaccination, and shingles

Postgraduate Medical Journal

Volumn 82, Issue 967, 2006, Pages 351-352

  Welsby, P D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; CHILDHOOD DISEASE; DISEASE SEVERITY; HERPES ZOSTER; HUMAN; INFECTION RISK; MORBIDITY; UNITED KINGDOM; UNITED STATES; VACCINATION;

ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; HERPES ZOSTER; HUMANS; RISK FACTORS; VACCINATION;

EID: 33646890179     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.038984     Document Type: Article

References (21)

1. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States. JAMA 2002;287:606-11.
2. WHO. Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998;73:241-8.
3. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001;32:1481-6.
4. Brisson M, Edmunds WJ, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001;127:305-14
5. Hope-Simpson RE. The nature of Herpes zoster: a long-term study and a new hyopothesis. Proc R Soc Med 1965;58:9-20.
6. Thomas SL, Wheeler JG, Hall AJ. Contacts with varicella or with children and protection against herpes zoster in adults. A case-controlled study. Lancet 2002;360:678-82.
7. Terada K, Hiraga Y, Kawano S, et al. Incidence of herpes zoster in paediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster. Kansenshogogaku Zasshi 1995;69:200-5.
8. Brisson M, Gay NJ, Edmunds WJ, et al. Exposure to varicella boosts immunity to herpes zoster: implications for mass vaccination against varicella. Vaccine 2002;20:2500-7
9. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis 2004;4:26-33.
10. Cunningham AL, Dworkin RH. The management of post-herpetic neuralgia. BMJ 2000;321:788-9.
11. Brisson M, Edmunds WJ, Gay NJ, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 2000;125:651-9.
12. Schuette MC, Hethcote HW. Modelling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 1999;61:1031-64.
13. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2344-6.
14. Guess HA, Broughton DD, Melton III LJ, et al. Epidemiology of herpes zoster in children and adolescents; a population-based study. Paediatrics 1985;76:512-17.
15. Baba K, Yabuuchi H, Takahashi M, et al. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study. J Paedtr 1986;108:372-7.
16. Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6.
17. Morgan D, Mahe C, Malamb S, et al. Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS 2001;15:223-9.
18. Veenstra J, Krol A, Van Praag RM, et al. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS 1995;9:1153-8.
19. Dehne KL, Dhlakama DG, Richter C, et al. Herpes zoster as an indicator of HIV infection in Africa. Trop Doc 1992;22:68-70.
20. Tyndall MW, Basio J, Agoki E, et al. Herpes zoster as the initial presentation of human immunodeficiency virus type 1 infection in Kenya. Clin Infect Dis 1995;21:1035-7.
21. Ragazzino MW, Melton III LJ, Kurland LT, et al. Risk of cancer after herpes zoster: a population-based study. N Engl J Med 1982;307:393-7.